Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,109.14
(
-0.24%
)
US TECH 100
25,920.00
(
-0.13%
)
Dow Jones
49,442.56
(
-0.01%
)
Brent Oil
90.68
(
-2.14%
)
Bitcoin
75,867.59
(
2.72%
)
News Focus
News Focus
Post# of 80490
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

BTH

Send PM Follow Ignore
Followers 16
Posts 4145
Boards Moderated 1
Alias Born 06/11/2010

BTH

Re: lax20m post# 12573

Thursday, 09/15/2011 12:41:03 PM

Thursday, September 15, 2011 12:41:03 PM

Post# of 80490
I think that if they partner Ponatinib with some other company OTHER than Merck, it pretty much takes a buyout off the table IMO.

Any time you have a company with multiple partners, in multiple drugs, it just begins to really complicate matters in M&A.

Not to say it hasn't been done, it's just less likely.

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today